HealthQuill drug resistance
The US Food and Drug Administration has approved Britain’s GSK Plc’s drug to treat urinary tract infections in adult women and girls above 12 years, according to the company.
Drugs Medical Pharma

GSK’s drug to fight urinary tract infections gets USFDA approval

HQ Team March 26, 2025: The US Food and Drug Administration has approved Britain’s GSK Plc’s drug to treat urinary tract infections in.

Read More
Cepheid Inc., a US molecular diagnostics company and a wholly-owned arm of Danaher Corporation has been granted WHO prequalification for its diagnostic tests for tuberculosis.
Uncategorized

Danaher’s Cepheid gets first WHO prequalification nod for TB tests

Cepheid Inc., a US molecular diagnostics company and a wholly-owned arm of Danaher Corporation has been granted WHO prequalification for its diagnostic tests.

Read More
Tuberculosis has emerged as the world’s top infectious disease with about 8.2 million people newly diagnosed with the illness last year — the highest on records since WHO began global monitoring in 1995.
Drugs Health Medical

Tuberculosis was the world’s top infectious disease killer last year

Tuberculosis has emerged as the world’s top infectious disease with about 8.2 million people newly diagnosed with the illness last year — the.

Read More
Drugs Health Pharma

World leaders call for action to combat antimicrobial resistance threat

HQ Team September 27, 2024: World leaders convened at the United Nations General Assembly (UNGA) on September 26, to address the escalating threat.

Read More
A family of antimicrobial compounds can neutralise necrotising fasciitis, a deadly bacterial skin infection that is also known as flesh-eating disease, when tested in mice, according to researchers at the Washington University School of Medicine in St. Louis.
Drugs Health Pharma

Scientists develop potential compound to neutralise flesh-eating bacteria

A family of antimicrobial compounds can neutralise necrotising fasciitis, a deadly bacterial skin infection that is also known as flesh-eating disease, when tested.

Read More
WHO issues global warning on drug-resistant Klebsiella Pneumonie pathogen
Drugs Health Pharma

WHO warns on drug-resistant Klebsiella Pneumonie spread

HQ Team August 4, 2024: The WHO has warned about the rising global incidence of hypervirulent and multi-resistant Klebsiella Pneumoniae (hvKp) infections. The.

Read More
About 70% of the 4.2 million deaths in 2019 attributed to air pollution were caused by cardiovascular conditions — ischaemic heart disease and stroke, according to a report.
Drugs Health Pharma

One billion people may get better health services by 2025: WHO says

HQ Team May 7, 2024: A target of one billion additional people enjoying better health and well-being is likely to be met by.

Read More
Better access to testing and diagnostic services is required to prevent sexually transmitted infections (STI) being acquired by more than one million people every day, the WHO stated.
Drugs Health Pharma

Require access to testing, diagnostic services to control STI: WHO

HQ Team July 26, 2023: Better access to testing and diagnostic services is required to prevent sexually transmitted infections (STI) being acquired by.

Read More
Pfizer’s last-stage experimental trials for treating multi-drug-resistant bacteria have yielded positive results, the US-based company announced.
Drugs Health Medical Pharma

Pfizer: ’Positive results’ emerge out of multi-drug-resistant trials

HQ Team June 1, 2023: Pfizer’s last-stage experimental trials for treating multi-drug-resistant bacteria have yielded positive results, the US-based company announced. The Phase.

Read More
WHO Malaria Africa
Drugs Health Pharma

Drug resistance to malaria on the rise in Africa, WHO says

Antimalarial drug resistance in Africa is a severe cause for concern and parasite resistance to artemisinin medicine has emerged in the Greater Mekong.

Read More